Tumor marker neuron-specific enolase (NSE) showed a declining trend over treatment and carcinoembryonic antigen (CEA) and cytokeratin 19 (CK19) remained within the normal range (Figure 1). The gene discussed is CEACAM5; the disease is neoplasm.